Viewing Opinion | StockChase
stockchase picture

Compiling comments that experts make about stocks while on public TV.

2017-03-20

Opinion for Valeant Pharmaceuticals (VRX-T)

Signal Price Bias Subject Owned
COMMENT $14.200 CAUTIOUS CANADIAN No

Struggling with massive amounts of debt, which was acquired when everything was looking great. The problem was, the assets they bought they probably overpaid for by using cheap paper. $30 billion is a lot of debt and he doesn’t know how they overcome it. He doesn’t like bottom fishing.

Lyle Stein
Sr. Portfolio & Managing Director, Vestcap Investment Management

No Comments.


You must be logged in to comment.